| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |